X-linked recessive Kallmann syndrome: A case report

Area of Science:

• Genetics
• Endocrinology
• Reproductive Medicine

Background:

• Kallmann syndrome (KS), or hypogonadotropic hypogonadism (HH), is a genetic disorder characterized by failure to complete puberty, hypogonadism, and infertility.
• KS affects approximately 1 in 4000 males and 1 in 50,000 females, with a higher prevalence in males.
• The condition's underlying genetic mechanisms and diagnostic challenges, particularly in males, are areas of ongoing research.

Observation:

• A 26-year-old male presented with symptoms of delayed puberty.
• Hormone level tests indicated delayed secretion of follicle-stimulating hormone and luteinizing hormone.
• Genetic screening identified an X-linked recessive KAL-1 mutation.

Findings:

• The patient was diagnosed with Kallmann syndrome due to a KAL-1 mutation, an X-linked recessive genetic cause.
• Treatment with pulsatile gonadotropin-releasing hormone (GnRH) via subcutaneous pump therapy led to significant increases in gonadotropin and testosterone levels.
• The study highlights the effectiveness of GnRH therapy in managing hypogonadism associated with KS.

Implications:

• This case underscores the importance of genetic testing in diagnosing Kallmann syndrome.
• Pulsatile GnRH therapy offers a viable treatment option for patients with KS, improving hormonal balance and potentially fertility outcomes.
• Further research into the genetic basis and therapeutic strategies for KS is warranted to improve patient management and genetic counseling.